Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

INTRODUCTION: While adjuvant therapy of early-stage non-small-cell lung cancer (NSCLC) is widely accepted, literature data concerning neoadjuvant treatment provide contradictory results with both improved and unaffected survival rates. Also, data concerning potential effects of neo-adjuvant therapy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chorostowska-Wynimko, J, Zaleska, J, Chabowski, M, Szpechcinski, A, Zych, J, Rudzinski, P, Langfort, R, Orlowski, T, Roszkowski-Sliz, K
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2009
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3521347/
https://ncbi.nlm.nih.gov/pubmed/20156723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-14-S4-42
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg